Genmab AS (GMAB)
US$ 20.181.51%
Price Chart
Key Statistics
Market Cap
$ 12.51B
P/E Ratio
11.87
Revenue (TTM)
$ 21.64B
Volume
1.05M
52W High
$ 30.06
52W Low
$ 17.23
Dividend Yield
0.00%
Beta
0.90
Technicals
50-Day MA
19.8533
200-Day MA
22.2803
52 Week High
30.06
52 Week Low
17.235
About GMAB
Genmab A/S, a biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark. The company markets EPKINLY and TEPKINLY for adu.
Employees
2638
Headquarters
Copenhagen, Denmark
CEO
Dr. Jan G.J. van de Winkel Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg